In this article, we’ll discuss the top 10 programming languages for AI and Natural Language Processing. You can skip our detailed analysis of global market trends for NLP and AI development and ...

Sanofi has sealed a $150 million licensing deal to gain access to Maze’s glycogen synthase 1 (GYS1) program, landing the company’s lead candidate MZE001 in the process. The licensing agreement ...

Maze is advancing an APOL1 small molecule inhibitor program, with preclinical data demonstrating dose dependent responses to treatment and supporting its potential as a treatment for certain APOL1 ...